Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer
June 4, 2026
USPTO Issues Patent Covering Use of XPro(TM) for Treatment of CNS Diseases
June 22, 2022
Related Post
-
-
Quantum-Si Announces the Expansion of the Proteus(TM) Roadshow
June 3, 2026
-
BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine
June 2, 2026
-
PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor Markets
June 1, 2026